U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022518

Expand all

DULERA (FORMOTEROL FUMARATE; MOMETASONE FUROATE)
0.005MG/INH;0.05MG/INH
Marketing Status: Prescription
Active Ingredient: FORMOTEROL FUMARATE; MOMETASONE FUROATE
Proprietary Name: DULERA
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.005MG/INH;0.05MG/INH
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022518
Product Number: 003
Approval Date: Aug 12, 2019
Applicant Holder Full Name: ORGANON LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
DULERA (FORMOTEROL FUMARATE; MOMETASONE FUROATE)
0.005MG/INH;0.1MG/INH
Marketing Status: Prescription
Active Ingredient: FORMOTEROL FUMARATE; MOMETASONE FUROATE
Proprietary Name: DULERA
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.005MG/INH;0.1MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022518
Product Number: 001
Approval Date: Jun 22, 2010
Applicant Holder Full Name: ORGANON LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
DULERA (FORMOTEROL FUMARATE; MOMETASONE FUROATE)
0.005MG/INH;0.2MG/INH
Marketing Status: Prescription
Active Ingredient: FORMOTEROL FUMARATE; MOMETASONE FUROATE
Proprietary Name: DULERA
Dosage Form; Route of Administration: AEROSOL, METERED; INHALATION
Strength: 0.005MG/INH;0.2MG/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022518
Product Number: 002
Approval Date: Jun 22, 2010
Applicant Holder Full Name: ORGANON LLC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top